Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 19, 2018
Pharmacy Choice - Pharmaceutical News - PCI Deepens Connections With the Greater Boston Life Sciences Community With the Signing of a Dozen Local Biotech Customers - November 19, 2018

Pharmacy News Article

 6/9/15 - PCI Deepens Connections With the Greater Boston Life Sciences Community With the Signing of a Dozen Local Biotech Customers

NEWBURYPORT, MA (Marketwired) 06/09/15 PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products, today announced strengthened ties with the Greater Boston life sciences community with the signing of a dozen local biotech and medtech customers.

"This year has been one of tremendous growth for PCI," said Ed Price, President of PCI Synthesis. "We're reached major milestones with customers, products, staff and awards, testament to the quality of our work and our commitment to put the customers first."

Local partnerships have been a growing trend in the industry and in PCI's business as well. According to Price, "Emerging pharma customers prefer the ease and practicality of working locally with partners such as PCI. There is greater collaboration, a faster buildup of trust and overall better communication when you work with a local partner as compared to a business located somewhere overseas or in a different time zone. The end result? A better product, saved time, and saved money tangible benefits that customers appreciate."

Many of PCI's newest customers are just a short drive from the company's Newburyport and Devens facilities, making it easy for customers to see the manufacturing in action and check on the status of their project. PCI stands apart from other contract manufacturing organizations because of its disciplined, proactive and focused project management approach, where transparency and accountability are built into every detailed project plan, milestone and communication.

"Unfortunately, that is not always the case with other CMOs, yet it is critically important for our customers," Price explained. "They want the job done right the first time, but that is not always their experience elsewhere. I believe that is another strong reason we have a record number of referrals."

PCI expects the commercialization of two products this year, active ingredients in generic drugs. To meet the demand in new customers and products in the pipeline, the company now stands at more than 110 employees, an increase of 22 percent over last year. It is actively hiring for a variety of new positions.

Due to this momentum and its growing reputation, PCI Synthesis was recently recognized as a Life Science Leader CMO Leadership Award recipient for the second year in a row in multiple categories. It won regulatory awards for both the midsize pharma and biotech industry sectors. The company has now won the top spot in every category in which the awards are given.

About PCI Synthesis

PCI Synthesis is a custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products. A contract manufacturing organization (CMO), PCI provides emerging and mid-sized pharmaceutical companies access to the expertise needed to develop and manufacture complex small molecules and APIs used in generic pharmaceuticals. To learn more about PCI Synthesis, its proprietary NCE development activities and process R&D capabilities please visit www.pcisynthesis.com.

Contact:
Margaret Bonilla
Birnbach Communications
603-548-0693
Email Contact

Source: PCI Synthesis




Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Nov 19: ADHD in Children & Adults: Etiology, Pathology, Pharmacotherapy
Last Chance
Nov 20: Acne Vulgaris: Comprehensive Pharmaceutical Care
Nov 26: COPD Update for Pharmacy Professionals
Nov 27: Management of Bipolar Disorder
Nov 28: A Primer to Paleo
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415